Bolis, S. (2013) “Clinical implications, safety, efficacy of Recombinant Human Granulocyte Colony-Stimulating Factors and Pegylated Equivalent”, Epidemiology, Biostatistics, and Public Health, 10(4). doi: 10.2427/8845.